Animal Sedative Market to Grow with a CAGR of 4.65% through 2030

Rising demand for veterinary care and advancements in veterinary medicine are expected to drive the Global Animal Sedative Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Animal Sedative Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the Global Animal Sedative Market stood at USD 132.04 Million in 2024 and is expected to reach USD 173.86 Million by 2030 with a CAGR of 4.65% during the forecast period. This can be attributed to growing veterinary tourism. Some countries have become popular destinations for veterinary tourism, attracting pet owners from around the world seeking high-quality and cost-effective veterinary care. As this trend continues to grow, it has a ripple effect on the global animal sedative market, as these facilities require a steady supply of sedatives for their international clientele. Pain management for animals is gaining prominence. Sedatives are not only used to calm animals but also to provide pain relief during procedures. Sedatives that effectively manage pain while maintaining safety are increasingly sought after.

The animal sedative market experienced significant disruption during the initial wave of the COVID-19 pandemic as governments worldwide implemented containment measures such as lockdowns and social distancing, leading to a substantial reduction in veterinary hospital and pharmacy operations. For instance, a December 2022 study by Faunalytics revealed that to prevent disease transmission, approximately 70% of clinics in the United States and Canada temporarily closed to the public, resulting in animals attending appointments without their owners. These clinics also faced critical shortages, with 82% experiencing deficits in pet food, medications, or personal protective equipment, and 56% running out of at least one of these essential items. Vaccines were particularly scarce. However, as pandemic restrictions eased, the animal sedative market is poised for growth in the coming years, driven by an increase in animal surgeries and the introduction of new veterinary sedative products.

Furthermore, factors contributing to the expansion of the animal sedatives market include the rising incidence of zoonotic diseases associated with surgical procedures, a growing pet population, and increased investment in veterinary product development. For example, according to the 2021-2022 National Pet Owners Survey by the American Pet Products Association (APPA), approximately 70% of U.S. households, equivalent to about 90.5 million families, own a pet, reflecting an increased focus on pet health and a likelihood of increased pet healthcare expenditure.

Research studies and developments aimed at comparing the efficacy of various veterinary sedative products are expected to fuel market growth. For instance, a December 2022 article in Frontiers reported that a single dose of romifidine or a combination of romifidine and lidocaine administered epidurally induced mild to moderate drowsiness and complete pain relief in the perineal and inguinal regions of donkeys. This technique offers convenience for providing analgesia as it is simple, cost-effective, and does not require specialized equipment. Such advancements in veterinary sedative utilization are projected to drive market growth in the forecast period.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Animal Sedative Market.”

The Global Animal Sedative Market is segmented into type, route of administration, regional distribution, and company.

The parenteral route is poised to be the fastest-growing segment in the Global Animal Sedative Market. While parenteral sedatives, delivered through injections or intravenous methods, have traditionally dominated the market due to their immediate and precise effects, their importance is increasing as they offer rapid and reliable sedation for emergency or critical situations. As veterinary practices continue to prioritize effective and swift sedation, particularly in high-stress environments or for complex procedures, the parenteral segment is experiencing rapid growth. This growth is further fueled by advancements in injectable sedative formulations, improving both safety and efficacy. Therefore, the parenteral segment is set to expand significantly as the market demands quick and efficient sedation solutions.

Based on region, Europe stands as the second dominant region in the global animal sedative market. Europe has a long-standing history of advancing veterinary practices, which has contributed to a high demand for animal sedatives in the region. The market in Europe is characterized by a well-established veterinary infrastructure, strong regulations, and a large number of veterinary professionals who require effective sedatives to manage a wide range of animals, from companion pets to livestock and exotic animals.

One of the key factors driving the dominance of Europe in the animal sedative market is the region’s robust livestock and farming industry. The agricultural sector in countries like Germany, France, the United Kingdom, and the Netherlands plays a crucial role in Europe’s veterinary market. Sedatives are essential for routine medical procedures such as vaccinations, examinations, and surgeries in livestock, particularly cattle, pigs, and poultry. Additionally, Europe’s demand for animal sedatives extends to the equine sector, where sedatives are regularly used for diagnostic imaging, minor surgeries, and handling large numbers of horses for events like races, veterinary exams, and breeding.

Major companies operating in Global Animal Sedative Market are:

• Zoetis Inc
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.
• Elanco Animal Health Inc
• Virbac S.A. 
• Dechra Pharmaceuticals Limited
• Orion Corporation
• Vetoquinol SA
• Bimeda, Inc. 
• Chanelle Pharma Group

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The global animal sedative market is poised for significant transformation in the coming years. The upcoming trends reflect the changing landscape of animal care, driven by the evolving expectations of pet owners, veterinarians, and regulators. As these trends continue to shape the industry, stakeholders in the animal sedative market must remain agile and responsive to meet the evolving needs of animals and their caregivers”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Animal Sedative Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine), By Route of Administration (Oral, Parenteral), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Animal Sedative Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Animal Sedative Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com